Charles River Laboratories (CRL)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,461,500 | 3,596,880 | 2,976,290 | 2,534,820 | 2,114,600 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $3,461,500K
= 0.00
Based on the provided data, Charles River Laboratories has consistently maintained a debt-to-equity ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has no debt on its balance sheet relative to its equity during this period. A debt-to-equity ratio of 0.00 suggests that Charles River Laboratories has not used debt financing as a source of capital, and its operations are primarily funded through equity. This can be seen as a positive financial indicator, signaling a lower risk of financial distress due to debt obligations and a stronger financial position in the long term. Charles River Laboratories' consistent zero debt-to-equity ratio over the years highlights its conservative financial management approach and potential resilience to economic downturns or market fluctuations.
Peer comparison
Dec 31, 2024